U.S. FDA advisers back Moderna vaccine for ages 6 and above
Reuters, 15 Jun 2022
Advisers to the U.S. Food and Drug Administration unanimously recommended that the agency authorize Moderna’s COVID vaccine for children and teens aged 6 to 17 years of age.
#covid #moderna #vaccine #fda #News #Reuters
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en